30% women fail to respond to cancer drug

SCIENTISTS now know why one in three women fail to respond to a leading breast cancer treatment.

About 30% of breast cancers do not respond to the drug tamoxifen which is used to treat thousands of Irish women.

Scientists at Cancer Research UK have now found a “key chemical switch” in breast tumours that resist the drug.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited